// App-Quantinova.ai

: Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Researchers

Presenter

  • Gregorio Campos-Cabrera

Principal Investigators

  • Esther Mendez-Garcia

  • Salvador Campos-Cabrera

  • Jose-Luis Campos-Villagomez

  • Virgina Campos-Cabrera

Medical Centers

  • Hematology and Blood Bank, Laboratorios Fatima de Michoacan, Morelia, Mexico

  • Clinical Pathology, Laboratorios Fatima de Michoacan, Morelia, Mexico

  • Patologia Clinica, Laboratorios Fatima de Michoacan, Morelia, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Multiple Myeloma

  • Obesity

  • Solid malignancies

Biomarkers

  • Creatinine

Drug/Treatment

  • Erythropoietin

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • rivaroxaban

  • Thalidomide

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved